SCLP — Scancell Holdings Income Statement
0.000.00%
Last trade - 00:00- £112.74m
- £121.25m
Annual income statement for Scancell Holdings, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.
R2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Preliminary |
| Revenue | |||||
| Total Revenue | 0 | 5.27 | 0 | 4.71 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | 4.75 | 0 | 4.47 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 20.5 | 17.2 | 18.3 | 17.9 | 17.4 |
| Operating Profit | -20.5 | -11.9 | -18.3 | -13.2 | -17.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -6.27 | -14.3 | -9.12 | -15.3 | -20.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.57 | -11.9 | -5.86 | -12.3 | -17.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.57 | -11.9 | -5.86 | -12.3 | -17.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.57 | -11.9 | -5.86 | -12.3 | -17.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.015 | -0.007 | -0.014 | -0.017 |